Literature DB >> 31736338

Urine α-fetoprotein and orosomucoid 1 as biomarkers of hepatitis B virus-associated hepatocellular carcinoma.

Zhu Zhan1,2,3, Yalan Guan1,2,3, Kenley Mew4, Weiqiong Zeng1,2,3, Mingli Peng1,2,3, Peng Hu1,2,3, Yixuan Yang1,2,3, Yi Lu1,2,3, Hong Ren1,2,3.   

Abstract

Hepatocellular carcinoma (HCC) is the sixth common malignant tumor worldwide, but current efficient and convenient screening methods remain lacking. This study aimed to discover a diagnostic or a screening biomarker from the urine of hepatitis B virus (HBV)-related HCC patients. We used iTRAQ coupled with mass spectrometry to identify candidate urinary proteins in a discovery cohort (n = 40). The selected proteins were confirmed using ELISA in a validation cohort (n = 140). Diagnostic performance of the selected proteins was assessed using receiver operating characteristic (ROC) and qualitative diagnostic analysis. A total of 96 differentially expressed proteins were identified. Urinary α-fetoprotein (u-AFP) and orosomucoid 1 (u-ORM1) were selected as target proteins by bioinformatics analysis and were significantly higher in HCC than in non-HCC patients, as validated by Western blot analysis and ELISA. u-AFP had a strong correlation with serum AFP-L3 (Pearson's r = 0.944, P < 0.0001), indicating that u-AFP may be derived from circulating blood. The area under the curve (AUC) of u-AFP was 0.795 with a sensitivity of 62.5% and a specificity of 95.4%, which showed no significantly difference with serum AFP (se-AFP). The AUC was 0.864 as u-AFP and u-ORM1 were combined, and they performed much better than u-AFP or u-ORM1 alone. Qualitative diagnostic analysis showed that the positive predictive value of u-AFP was 90.1% and the diagnostic sensitivity of parallel combination of u-AFP and u-ORM1 was 85.1%. Taken together, AFP and ORM1 in the urine may be used as a diagnostic or screening biomarker of HCC, and studies on large samples are needed to validate the result.NEW & NOTEWORTHY This study provides a novel way to find biomarkers of hepatocellular carcinoma (HCC) and a new perspective of α-fetoprotein clinical application. The urine reagent strips may be helpful in high epidemic areas of HCC and in low-resource settings.

Entities:  

Keywords:  biomarker; hepatocellular carcinoma; proteomic; urine; α-fetoprotein

Mesh:

Substances:

Year:  2019        PMID: 31736338     DOI: 10.1152/ajpgi.00267.2019

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  8 in total

1.  Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

Authors:  Agostino Colli; Tin Nadarevic; Damir Miletic; Vanja Giljaca; Mirella Fraquelli; Davor Štimac; Giovanni Casazza
Journal:  Cochrane Database Syst Rev       Date:  2021-04-15

Review 2.  Review: Detection and quantification of proteins in human urine.

Authors:  Sultan Aitekenov; Abduzhappar Gaipov; Rostislav Bukasov
Journal:  Talanta       Date:  2020-10-14       Impact factor: 6.057

3.  Orosomucoid in liver diseases.

Authors:  Gulsum Ozlem Elpek
Journal:  World J Gastroenterol       Date:  2021-12-07       Impact factor: 5.742

4.  Salivary orosomucoid 1 as a biomarker of hepatitis B associated hepatocellular carcinoma.

Authors:  Jiaoxia He; Zhongling Zheng; Tingting Liu; Yupei Ao; Yixuan Yang; Huaidong Hu
Journal:  Sci Rep       Date:  2022-09-12       Impact factor: 4.996

Review 5.  Biomarkers for hepatocellular carcinoma based on body fluids and feces.

Authors:  Ming-Cheng Guan; Wei Ouyang; Ming-Da Wang; Lei Liang; Na Li; Ting-Ting Fu; Feng Shen; Wan-Yee Lau; Qiu-Ran Xu; Dong-Sheng Huang; Hong Zhu; Tian Yang
Journal:  World J Gastrointest Oncol       Date:  2021-05-15

6.  Urinary Proteomics Identifying Novel Biomarkers for the Diagnosis of Adult-Onset Still's Disease.

Authors:  Yue Sun; Fan Wang; Zhuochao Zhou; Jialin Teng; Yutong Su; Huihui Chi; Zhihong Wang; Qiongyi Hu; Jinchao Jia; Tingting Liu; Honglei Liu; Xiaobing Cheng; Hui Shi; Yun Tan; Chengde Yang; Junna Ye
Journal:  Front Immunol       Date:  2020-09-04       Impact factor: 7.561

Review 7.  Advances in High Throughput Proteomics Profiling in Establishing Potential Biomarkers for Gastrointestinal Cancer.

Authors:  Md Zahirul Islam Khan; Shing Yau Tam; Helen Ka Wai Law
Journal:  Cells       Date:  2022-03-11       Impact factor: 6.600

8.  Proteome Analysis of Urinary Biomarkers in a Bovine IRBP-Induced Uveitis Rat Model via Data-Independent Acquisition and Parallel Reaction Monitoring Proteomics.

Authors:  Weiwei Qin; Xuyan Qin; Lujun Li; Youhe Gao
Journal:  Front Mol Biosci       Date:  2022-02-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.